Edition:
United States

Ypsomed Holding AG (YPSN.S)

YPSN.S on Swiss Exchange

148.50CHF
18 May 2018
Change (% chg)

CHF-1.40 (-0.93%)
Prev Close
CHF149.90
Open
CHF150.00
Day's High
CHF150.00
Day's Low
CHF145.30
Volume
19,452
Avg. Vol
20,170
52-wk High
CHF228.70
52-wk Low
CHF132.50

Chart for

About

Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as... (more)

Overall

Beta: 0.44
Market Cap(Mil.): CHF2,027.75
Shares Outstanding(Mil.): 12.65
Dividend: 1.30
Yield (%): 0.81

Financials

  YPSN.S Industry Sector
P/E (TTM): 43.72 32.19 32.75
EPS (TTM): 3.67 -- --
ROI: 15.36 13.89 14.38
ROE: 16.24 16.72 16.07

BRIEF-Ypsomed FY Net Profit Increases To CHF 52.1 Million

* FY CONSOLIDATED SALES OF CHF 466.1 MILLION (PRIOR YEAR: CHF 389.6 MILLION)

May 24 2018

BRIEF-Ypsomed Holding Establishes Its First Subsidiary In Canada

* ESTABLISHES ITS FIRST SUBSIDIARY IN NORTH AMERICA, CANADA Source text - https://bit.ly/2pNgRJw Further company coverage: (Gdynia Newsroom)

Mar 27 2018

BRIEF-Ypsomed sees temporary profit decline in 2019/20, then rebound

* YPSOMED SAYS FOR THE NEXT FINANCIAL YEAR 2018/19, YPSOMED CONTINUES TO EXPECT AN INCREASED OPERATING PROFIT

Mar 07 2018

Earnings vs. Estimates